A phase I intraoperative optical imaging study of CLR1502 in patients undergoing lumpectomy surgery

Trial Profile

A phase I intraoperative optical imaging study of CLR1502 in patients undergoing lumpectomy surgery

Planning
Phase of Trial: Phase I

Latest Information Update: 11 Jun 2015

At a glance

  • Drugs CLR 1502 (Primary)
  • Indications Breast cancer
  • Focus Diagnostic use; Proof of concept
  • Most Recent Events

    • 11 Jun 2015 According to a company media release, Cellectar Biosciences announced that after review of the company's IND application, the US FDA has determined that CLR1502 will be evaluated as a combination product and assigned to the Center for Devices and Radiological Health (CDRH). The FDA has advised Cellectar that it will need to submit a new IND application for the combination product prior to initiating its planned proof-of-concept trial in breast cancer surgery.
    • 07 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top